ADVANCED VIRAL RESEARCH CORP
POS AM, EX-23.1, 2000-09-25
PHARMACEUTICAL PREPARATIONS
Previous: ADVANCED VIRAL RESEARCH CORP, POS AM, EX-10.42, 2000-09-25
Next: ADVANCED VIRAL RESEARCH CORP, POS AM, EX-27.1, 2000-09-25



<PAGE>   1
                                                                    EXHIBIT 23.1

              CONSENT OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS

We hereby consent to the use in the Prospectus constituting part of this Post
Effective Amendment No. 1 to the registration statement on Form S-1 of Advanced
Viral Research Corp. of our report dated January 26, 2000 (except for the fourth
paragraph of Note 12, which is dated March 9, 2000) relating to the consolidated
financial statements of Advanced Viral Research Corp. as of December 31, 1999
and 1998 and for each of the three years in the period ended December 31, 1999
appearing in such Prospectus, which report contains an explanatory paragraph
that describes a condition that raises substantial doubt as to the ability of
Advanced Viral Research Corp. to continue as a going concern. We also consent to
the references to us under the heading "EXPERTS" in the Prospectus.

                                                  /s/ RACHLIN COHEN & HOLTZ LLP
                                                  -----------------------------
                                                  RACHLIN COHEN & HOLTZ LLP

Miami, Florida
September 22, 2000




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission